TreviPay, a fully managed B2B payments platform, today announced the availability of the Growth Center, a set of capabilities ...

Analyst Insight: Many biotech firms struggle to manage the order-to-cash (O2C) cycle effectively because large contract manufacturers (CMOs) often handle physical shipping, while the firm retains ...

Fantasy fans split over whether to shell out for conservative media outlet's big budget Arthurian fantasy. By James Hibberd Writer-at-Large Daily Wire released The Pendragon Cycle‘s first two episodes ...

Reliance Industries, the heavyweight of Dalal Street, is set to announce its Q3 earnings today, and the numbers could decide market direction for the coming week. Expectations are high as investors ...

Dr. Witt is the author of “The Radical Fund: How a Band of Visionaries and a Million Dollars Upended America.” In a year when the United States seemed more split than ever, Americans united in one way ...

It's become fashionable of late to dismiss bitcoin's BTC $66,797.21 four-year cycle — and the inevitable boom and bust it brings — as an anachronism. Just in the past week, Bitwise's Matt Hougan and ...

The Daily Wire has released a new trailer for its debut live-action scripted television series, “The Pendragon Cycle: Rise of the Merlin,” marking the conservative media company’s most ambitious move ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.

The Pendragon Cycle: Rise of the Merlin looks huge, dramatic, and honestly super cool. Fans who have been waiting forever to see this world come alive finally have a date, a streaming platform, and a ...